Physician profile
Bridget Rubel
NPI 1639641640
$2,208.69
in general payments reported to CMS, 2019-2025
8 companies · $1,647 in 2025
The $1,647 reported for 2025 was more than what 93% of Community Health (Nurse Practitioner) providers received nationally (typical 2025 total: $139).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.83 · 2022: $65.34 · 2023: $31.66 · 2024: $385 · 2025: $1,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,063.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $809.53 | 2024-2025 | Brixadi |
| Astrazeneca Pharmaceuticals LP | $667.56 | 2025 | Airsupra, Breztri |
| Alkermes, INC. | $345.51 | 2024-2025 | Vivitrol |
| Orexo US, INC. | $242.93 | 2021-2025 | Zubsolv |
| Abbvie INC. | $102.45 | 2025 | |
| Hikma Pharmaceuticals USA | $14.60 | 2021 | |
| Indivior INC. | $13.81 | 2022 | |
| Almatica Pharma LLC | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Rubel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.